The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Erectile Dysfunction Therapeutic Market Research Report 2025
Synopsis
Erectile dysfunction (ED) is the type of sexual dysfunction when a man cannot maintain a firm erection of the penis or coitus.
The global Oral Erectile Dysfunction Therapeutic market was valued at US$ 963 million in 2023 and is anticipated to reach US$ 1492.3 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Erectile Dysfunction Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Erectile Dysfunction Therapeutic.
Report Scope
The Oral Erectile Dysfunction Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Erectile Dysfunction Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Erectile Dysfunction Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
Teva Pharma
S.K. Chemicals
Seoul Pharma
CSBIO.
Segment by Type
Protein
Hormones
Other
Segment by Application
Age <20
Age 20-30
Age 31-40
Age 41-50
Age >50
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Erectile Dysfunction Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Erectile dysfunction (ED) is the type of sexual dysfunction when a man cannot maintain a firm erection of the penis or coitus.
The global Oral Erectile Dysfunction Therapeutic market was valued at US$ 963 million in 2023 and is anticipated to reach US$ 1492.3 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Erectile Dysfunction Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Erectile Dysfunction Therapeutic.
Report Scope
The Oral Erectile Dysfunction Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Erectile Dysfunction Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Erectile Dysfunction Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
Teva Pharma
S.K. Chemicals
Seoul Pharma
CSBIO.
Segment by Type
Protein
Hormones
Other
Segment by Application
Age <20
Age 20-30
Age 31-40
Age 41-50
Age >50
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Erectile Dysfunction Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Erectile Dysfunction Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protein
1.2.3 Hormones
1.2.4 Other
1.3 Market by Application
1.3.1 Global Oral Erectile Dysfunction Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Age <20
1.3.3 Age 20-30
1.3.4 Age 31-40
1.3.5 Age 41-50
1.3.6 Age >50
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Erectile Dysfunction Therapeutic Market Perspective (2019-2030)
2.2 Oral Erectile Dysfunction Therapeutic Growth Trends by Region
2.2.1 Global Oral Erectile Dysfunction Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Erectile Dysfunction Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Oral Erectile Dysfunction Therapeutic Market Dynamics
2.3.1 Oral Erectile Dysfunction Therapeutic Industry Trends
2.3.2 Oral Erectile Dysfunction Therapeutic Market Drivers
2.3.3 Oral Erectile Dysfunction Therapeutic Market Challenges
2.3.4 Oral Erectile Dysfunction Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Erectile Dysfunction Therapeutic Players by Revenue
3.1.1 Global Top Oral Erectile Dysfunction Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Oral Erectile Dysfunction Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Erectile Dysfunction Therapeutic Revenue
3.4 Global Oral Erectile Dysfunction Therapeutic Market Concentration Ratio
3.4.1 Global Oral Erectile Dysfunction Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Erectile Dysfunction Therapeutic Revenue in 2023
3.5 Oral Erectile Dysfunction Therapeutic Key Players Head office and Area Served
3.6 Key Players Oral Erectile Dysfunction Therapeutic Product Solution and Service
3.7 Date of Enter into Oral Erectile Dysfunction Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Erectile Dysfunction Therapeutic Breakdown Data by Type
4.1 Global Oral Erectile Dysfunction Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Type (2025-2030)
5 Oral Erectile Dysfunction Therapeutic Breakdown Data by Application
5.1 Global Oral Erectile Dysfunction Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Oral Erectile Dysfunction Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Erectile Dysfunction Therapeutic Market Size (2019-2030)
6.2 North America Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024)
6.4 North America Oral Erectile Dysfunction Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Erectile Dysfunction Therapeutic Market Size (2019-2030)
7.2 Europe Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024)
7.4 Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Erectile Dysfunction Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Erectile Dysfunction Therapeutic Market Size (2019-2030)
9.2 Latin America Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Oral Erectile Dysfunction Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral Erectile Dysfunction Therapeutic Introduction
11.1.4 Eli Lilly Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral Erectile Dysfunction Therapeutic Introduction
11.2.4 Pfizer Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Oral Erectile Dysfunction Therapeutic Introduction
11.3.4 Bayer Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Teva Pharma
11.4.1 Teva Pharma Company Detail
11.4.2 Teva Pharma Business Overview
11.4.3 Teva Pharma Oral Erectile Dysfunction Therapeutic Introduction
11.4.4 Teva Pharma Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.4.5 Teva Pharma Recent Development
11.5 S.K. Chemicals
11.5.1 S.K. Chemicals Company Detail
11.5.2 S.K. Chemicals Business Overview
11.5.3 S.K. Chemicals Oral Erectile Dysfunction Therapeutic Introduction
11.5.4 S.K. Chemicals Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.5.5 S.K. Chemicals Recent Development
11.6 Seoul Pharma
11.6.1 Seoul Pharma Company Detail
11.6.2 Seoul Pharma Business Overview
11.6.3 Seoul Pharma Oral Erectile Dysfunction Therapeutic Introduction
11.6.4 Seoul Pharma Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.6.5 Seoul Pharma Recent Development
11.7 CSBIO.
11.7.1 CSBIO. Company Detail
11.7.2 CSBIO. Business Overview
11.7.3 CSBIO. Oral Erectile Dysfunction Therapeutic Introduction
11.7.4 CSBIO. Revenue in Oral Erectile Dysfunction Therapeutic Business (2019-2024)
11.7.5 CSBIO. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
